Therapeutic Advantage of Recombinant Human Plasminogen Activator in Endocarditis: Evidence from Experiments in Rabbits

Summary

In infective endocarditis vegetations are stabilized by fibrin. To learn if fibrin digestion would be therapeutic, experimental endocarditis was induced in rabbits by inoculation with a platelet-aggregating strain (Agg+) of Streptococcus sanguis and treated with recombinant tissue plasminogen activator (rt-PA), rt-PA with penicillin, or penicillin alone. Control rabbits were inoculated with saline. All treatments of Agg+ endocarditis reduced the mass of valvular vegetations and clinical signs of endocarditis, including the frequency of left axis deviation and heart ischemia. rt-PA with penicillin was more effective than penicillin or rt-PA alone, reducing the mass of vegetations and clinical signs to that of saline controls. Within 50 min, rt-PA cleared 5-fold more ¹¹¹Indium-labelled platelets from the heart than untreated rabbits and 1.4-fold more after 3 days. Combined with penicillin, thrombolytic therapy for human endocarditis should be reconsidered.

• References

• 1 Durack DT. Experimental bacterial endocarditis: IV Structure and evaluation of very early lesions. J Exp Path 1975; 115: 81-89
• 2 Carbon C. Experimental endocarditis: A review of its relevance to human endocarditis. J Antimicrobal Chemotherapy 1993; 31 Suppl D 71-85
• 3 Bode C, Schuler G, Nordt T, Schönermark S, Baumann H, Richardt G, Dietz R, Gurewich V, Kübler W. Intravenous thrombolytic therapy with a combination of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator in acute miocardial infarction. Circulation 1990; 81: 907-913
• 4 Stuttle AW J, Klosok J, Peters AM, Henderson BL, Lavender JP. Imaging venous thrombosis with Indium-111 labelled P256 Fab. In Biotechnology of Plasma Proteins. Albertini A, Lenfant CL, Mannucci PM, Sixma JJ. (eds) Basel: Karger; 1991. pp 200-204
• 5 Buiting AG, Thompson. Emeis JJ, Mattie H, Brommer JP, van Furth R. Effect of tissue-type plasminogen activator (t-PA) on the treatment with ben-zylpenicillin of rabbits with experimental Streptococcus sanguis endocarditis. J Infect Dis 1989; 159: 780-784
• 6 Herzberg MC, MacFarlane GD, Gong K, Armstrong NN, Witt AR, Erickson PR, Meyer MW. The platelet interactivity phenotype of Streptococcus sanguis influences the course of experimental endocarditis: Infect Immun. 1992; 60: 4809-4818
• 7 Sokal RR, Rohlf FJ. Transformations. In: Biometry: The Principles and Practice of Statistics in Biological Research. New York: WH Freeman Company; 1981. pp 417-423
• 8 DiNubile MJ, Calderwood SB, Steinhaus DM, Karchmer AW. Cardiac conduction abnormalities complicating native valve infective endocarditis. Am J Cardiol 1986; 58: 1213-1217
• 9 Lijnen HR, Collen D. New strategies in the development of thrombolytic agents. In: Biotechnology of Plasma Proteins. Albertini A, Lenfant CL, Mannucci PM, Sixma JJ. eds Basel: Karger; 1991. pp 69-72